A Veteran Reflects on CAR T-Cell Therapy and Isolation
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
Watch
Side Effects of BGB-16673 Appear Manageable in Early CLL Study
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
A Cancer Thriver Breaks Down Her Definition of Survivorship
Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.
CAR T-Cell Therapy Leads to Remission in Retired Air Force Pilot With Lymphoma
Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.
Comforting Lentil Soup Recipe to Ease Side Effects During Cancer Care
Watch oncology dietitian Kanisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
What Patients Should Know About Living With WM and the Road Ahead
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Providing Advocacy and Support for Those With Pediatric Brain Cancer
Kasey Rangan discusses ways that families of patients with pediatric brain cancer can advocate for themselves, especially when it comes to mental health.
What Should Patients with Multiple Myeloma Know After ASCO 2025?
Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies following the 2025 ASCO Meeting.
Improving Distant Control in Lung Cancer With JNJ-1900 and Keytruda
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
Breaking Down Clinical Trial Participation in Kidney Cancer: Is it Right for You?
Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.
Personalized Therapy Helps Tailor Treatment for GIST
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Can ctDNA Help Guide Surgical Decision Making in Breast Cancer
Dr. Rita Mukhtar and Dr. Joshua K. Sabari discuss the role of ctDNA to guide surgical decision-making after neoadjuvant chemo in breast cancer treatment.
Experts Walk Through Recent Hematologic Malignancy Treatment Updates
Dr. Raajit K. Rampal and Dr. Joshua K. Sabari walk through updates for patients in the treatment of blood cancers, including polycythemia vera.
ctDNA-Guided Therapy May Improve Breast Cancer Outcomes
For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.
Zanzalintinib Triplet Combo Under Investigation in Kidney Cancer Subgroups
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
New Treatment Options Emerging Across Lung Cancer Subtypes
Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, according to experts.
Understanding the Whole Person Behind their Cancer Diagnosis
Dr. Joshua K. Sabari and Jackie Herigodt sat down to discuss the importance of knowing a patient beyond their cancer diagnosis.
Delving Into Brain Cancer Treatment Takeaways Following ASCO 2025
The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs. Joshua K. Sabari and Manmeet Singh Ahluwalia.
Breaking Down the VERIFY Trial for Patients With Polycythemia Vera
Dr. Aaron Gerds breaks down the outcomes of the phase 3 VERIFY trial, investigating rusfertide, for patients with polycythemia vera, a type of blood cancer.
What Should Patients With Lung Cancer Know After ASCO 2025?
Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.
Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025
Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.
A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment
Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.
What Patients With Genitourinary Cancers Should Know After ASCO 2025
Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology
How to Prepare for Self-Advocacy After a Cancer Diagnosis
Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.
Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.
You Are Not Alone While Building a Support Team During Cancer Care
Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.
Protect Your Healing by Lowering Chemical Exposure After Cancer Diagnosis
It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden both before and after treatment.
Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.
Understanding Supportive Care Needs in Younger Women With Cancer
Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life.
